ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,213Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 680

$1.31M Total Retail Price of All Prescriptions

Rank: 38 out of 680

672 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 672 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

26% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

4% of this provider’s 17,793 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 726 603 1 6
LEVOTHYROXINE SODIUM 604 525 2 2
AMLODIPINE BESYLATE 555 479 3 1
HYDROCODONE-ACETAMINOPHEN 545 353 S3 4 4
LISINOPRIL 503 387 5 5
GABAPENTIN 488 326 6 15
WARFARIN SODIUM 467 397 7 20
OMEPRAZOLE 452 358 8 7
SIMVASTATIN 365 275 9 3
POTASSIUM CHLORIDE 335 259 10 14
PRAVASTATIN SODIUM 331 267 11 10
METOPROLOL TARTRATE 330 277 12 12
NAMENDA 319 319 13 35
DONEPEZIL HCL 316 300 14 27
TRAMADOL HCL 298 232 15 18
PANTOPRAZOLE SODIUM 281 246 16 30
NEXIUM 278 222 17 16
MEGESTROL ACETATE 254 244 R 18 88
METFORMIN HCL 246 163 19 8
METOPROLOL SUCCINATE 244 208 20 13
ESCITALOPRAM OXALATE 238 223 21 45
FAMOTIDINE 225 183 22 89
JANTOVEN 215 193 23 147
CLOPIDOGREL 213 157 24 26
MELOXICAM 212 153 25 24
POLYETHYLENE GLYCOL 3350 210 191 26 62
DOXYCYCLINE HYCLATE 204 172 27 95
KLOR-CON M20 202 167 28 61
LANTUS 194 155 29 49
QUETIAPINE FUMARATE 184 161 30 64
PROMETHAZINE HCL 183 123 R 31 96
ZOLPIDEM TARTRATE 168 95 32 17
SERTRALINE HCL 163 138 33 28
CYMBALTA 162 112 34 46
CIPROFLOXACIN HCL 160 132 35 57
PREDNISONE 149 124 36 50
ALENDRONATE SODIUM 146 141 37 32
FLUOXETINE HCL 145 129 38 74
DIGOXIN 144 138 39 58
CITALOPRAM HBR 139 126 40 22
CARBIDOPA-LEVODOPA 134 115 41 117
ATENOLOL 130 86 42 19
ROPINIROLE HCL 129 90 43 99
PLAVIX 129 100 43 39
GEMFIBROZIL 120 83 45 106
DIOVAN 119 105 46 31
CARVEDILOL 118 95 47 23
IPRATROPIUM-ALBUTEROL 118 113 47 207
KLOR-CON M10 117 106 49 127
CEFUROXIME 115 89 50 179
TRAZODONE HCL 113 81 51 48
DIVALPROEX SODIUM 113 109 51 110
ATORVASTATIN CALCIUM 112 70 53 11
EXELON 110 106 54 112
ISOSORBIDE MONONITRATE ER 110 96 54 59
HUMULIN R 109 86 56 195
MIRTAZAPINE 108 102 57 78
LYRICA 101 56 58 77
GLIPIZIDE 97 40 59 63
TAMSULOSIN HCL 97 91 59 34
FLUCONAZOLE 97 85 59 139
COLCRYS 96 64 62 166
AMLODIPINE BESYLATE-BENAZEPRIL 96 76 62 43
GLIMEPIRIDE 96 94 62 29
CLONIDINE HCL 94 65 65 36
LEVETIRACETAM 93 67 66 120
SANTYL 93 80 66 170
FENTANYL 92 74 S2 68 183
CARISOPRODOL 88 42 R 69 83
HYDROCHLOROTHIAZIDE 88 59 69 9
RANITIDINE HCL 88 74 69 56
NYSTATIN 87 81 72 191
NOVOLIN R 86 69 73 113
ABILIFY 82 62 74 178
LEVOFLOXACIN 79 69 75 97
PROAIR HFA 79 40 75 67
NITROFURANTOIN 78 70 77 269
LEXAPRO 77 75 78 128
DIVALPROEX SODIUM ER 77 63 78 148
IBANDRONATE SODIUM 76 52 80 288
DETROL LA 76 75 80 169
RAMIPRIL 74 57 82 69
RISPERIDONE 73 68 83 80
ADVAIR DISKUS 72 45 84 53
SEROQUEL 72 68 84 123
JANUVIA 70 49 86 60
METOCLOPRAMIDE HCL 70 40 86 118
ZIPRASIDONE HCL 69 65 88 229
VESICARE 64 55 89 176
DIOVAN HCT 64 55 89 55
CYPROHEPTADINE HCL 64 60 R 89 297
AMIODARONE HCL 63 49 92 158
TRIAMCINOLONE ACETONIDE 63 47 92 199
AMOX TR-POTASSIUM CLAVULANATE 63 48 92 124
PRAMIPEXOLE DIHYDROCHLORIDE 62 51 95 204
LOSARTAN POTASSIUM 61 54 96 21
FORTEO 60 45 97 429
NASONEX 60 53 97 197
CRESTOR 59 36 99 25
AZITHROMYCIN 58 44 100 42
NITROFURANTOIN MONO-MACRO 58 49 100 172
LACTULOSE 58 48 100 92
ESTRADIOL 58 51 R 100 134
ZETIA 58 39 100 87
SPIRONOLACTONE 55 55 105 82
BUSPIRONE HCL 53 44 106 144
AMITRIPTYLINE HCL 52 23 R 107 47
PEN NEEDLE 51 25 108 122
GLIPIZIDE XL 51 51 108 142
METHOCARBAMOL 50 36 R 110 251
BONIVA 50 32 110 463
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.